Page last updated: 2024-09-03

nitisinone and Cardiomyopathy, Hypertrophic

nitisinone has been researched along with Cardiomyopathy, Hypertrophic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al Jurayyan, NA; Al-Jarallah, AS; Al-Nemri, A; Babiker, A; Hasanato, R; Kambal, MA; Mohamed, S1
André, N; Jubin, V; Ovaert, C; Roquelaure, B1

Other Studies

2 other study(ies) available for nitisinone and Cardiomyopathy, Hypertrophic

ArticleYear
Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy.
    BMC research notes, 2013, Sep-09, Volume: 6

    Topics: Cardiomyopathy, Hypertrophic; Cyclohexanones; Food, Formulated; Heptanoates; Homozygote; Humans; Hydrolases; Infant; Male; Mutation; Nitrobenzoates; Siblings; Treatment Outcome; Tyrosinemias

2013
Successful treatment of severe cardiomyopathy with NTBC in a child with tyrosinaemia type I.
    Journal of inherited metabolic disease, 2005, Volume: 28, Issue:1

    Topics: Amino Acid Metabolism, Inborn Errors; Cardiomyopathy, Hypertrophic; Cyclohexanones; Echocardiography; Enzyme Inhibitors; Humans; Hypertrophy, Left Ventricular; Infant; Male; Nitrobenzoates; Tyrosine; Tyrosinemias

2005